|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | |
| A61K 31/519 | 
| (11) | Number of the document | 3354753 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 18160989.2 | 
| Date of filing the European patent application | 2010-04-05 | |
| (97) | Date of publication of the European application | 2018-08-01 | 
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 | 
| (46) | Date of publication of the claims translation | 
| (30) | Number | Date | Country code | 
| 16713609 P | 2009-04-06 | US | 
| (72) | 
                    
                    
                    
                    
                    WOLFGANG, Curt, US  
                    
                    
                    
                    
                    POLYMEROPOULOS, Mihael, H, US  | 
| (73) | Vanda Pharmaceuticals Inc.,
                2200 Pennsylvania Avenue  Suite 300-E, Washington, DC 20037,
                US | 
| (54) | METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE | 
| METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE |